The health device market is flooded with diverse marketing campaigns nowadays. Many brands quickly go viral via short-video traffic yet neglect fundamental R&D and the development of quality control systems. Founded in 2010, Hainice specializes in diabetes monitoring. Upholding a long-term mindset, it strives to build a reliable domestic brand that stands the test of time.

The brand follows a clear business logic: traffic only brings short-term exposure. Product quality, independent technology and sustained services lay the groundwork for lasting market presence. To this end, the enterprise consistently boosts investment in research and development. It never cuts budgets for laboratory upgrades and testing equipment, and iterates technologies continuously to address pain points in household blood glucose monitoring. Independent R&D has yielded a portfolio of intellectual property rights, freeing the brand from over-reliance on third-party technical solutions.

At the production stage, the company maintains high-standard hardware investment, with independent zones separated for manufacturing and quality inspection. Professional testing instruments are deployed alongside multiple recheck procedures to guarantee stable performance of every device upon delivery.

Targeting China’s large population with chronic diseases, Hainice adheres to its original aspiration of “making technology accessible to people”. It rejects premium-driven marketing, optimizes supply chains and production workflows, and reduces intermediate costs. This keeps blood glucose monitors and supporting consumables affordably priced, easing the financial burden of long-term home monitoring. Meanwhile, the brand has built a nationwide offline service network, creating dual channels for online consultation and after-sales support offline. Users across urban and rural areas can access timely services including consumable supply, equipment calibration and operation guidance.

For more than a decade, Hainice has delved deep into the segmented diabetes care track. Instead of chasing short-lived trends, it concentrates on strengthening capabilities across the whole industrial chain. From independent technology accumulation and standardized production control to nationwide service rollout, the brand builds public trust in domestic blood glucose device manufacturers with tangible strengths. It proves to the market that local medical device brands can win public recognition through consistent quality, rather than marketing hype.